Homoharringtonine (HHT, Ceflatonin, Myelostatb) is a different drug from hydroxyurea and most research into it has been done in regards to leukemia. I would be very interested in learning which properties of homoharringtonine would apply in thalassemia, if in fact, this is the drug that has been prescribed. It is quite possible that there has been research done on homoharringtonine in India, that has not taken place in the US due to regulations. Even though it is a naturally occurring drug, there are issues about consistency and potency that have slowed research in the west. Please keep us updated on this.